CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 77 enrolled
Drug / intervention
Vitamin D3 +1 moredrug
Likely dose
Vitamin D3 0.3 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04278573
NCT04278573Phase 2Completed
CompareCT.gov

Efficacy of Intralesional Vitamin D Injection for Treatment of Common Warts: A Randomized Controlled Trial

Stephen P. Merry·interventional·Posted Feb 20, 2020·Updated Apr 30, 2024

In Brief

A Phase 2 clinical trial evaluating Vitamin D3 and Placebo for Warts. Completed, enrolled 77 participants across 1 site.

Detailed Summary

Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWarts
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedFeb 20, 2020
Enrollment StartOct 20, 2020
Primary CompletionApr 4, 2023
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 6.4 years ago

Interventions

Vitamin D3drug

Intralesional injection of 0.3 ml 40,000 IU/ml vitamin D3 into one wart

Placebodrug

0.3 ml injection of sterilized sesame oil with no active study ingredient